Lunit announced the signing of a supply agreement with Roche and Microsoft Azure to sell Lunit Insight MMG, an artificial intelligence-based mammography image analysis system, to the Middle East.
“Roche has been continuously developing breast cancer research for the past 30 years and has contributed a lot to breast cancer treatment by developing related drugs. Microsoft Azure is gradually expanding the market as a global cloud service leader,” Lunit CEO Suh Beom-Seok said. “Therefore, we expect the contract to accelerate our sales in the region.”
Lunit has signed contracts with worldwide medical equipment firms such as GE Healthcare, Philips, and Fujifilm to provide AI image analysis solutions. The company’s current arrangement is noteworthy since it has allowed it to expand its sales channels by collaborating with some of the world’s leading biopharmaceutical and IT organizations.
Lunit will deliver Lunit Insight MMG to Roche’s Middle East division for the next three years, and Roche will use Lunit Insight MMG for breast cancer screening at medical institutions in the Middle East utilizing Microsoft Azure’s web-based cloud, according to the agreement.
Within the first part of the year, Lunit intends to introduce its Lunit Insight MMG Web service in the Middle East market. Together with Roche, the company is contemplating a plan to supply other solutions, such as items linked to image archiving and communication systems used in medical institutions, and Lunit Insight CXR, a lung cancer diagnosis solution, in addition to cloud services.
